Last Updated 26 July 2021.
4 Vaccines Approved for Use in Republic of Korea
-
Moderna
mRNA-1273- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 64 countries
21 trials in 4 countries
Approval Source: modernatx.gcs-web.com
-
Pfizer/BioNTech
BNT162b2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 97 countries
24 trials in 16 countries
Approval Source: asia.nikkei.com
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 56 countries
11 trials in 17 countries
Approval Source: mfds.go.kr
-
Oxford/AstraZeneca
AZD1222- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 119 countries
33 trials in 19 countries
Approval Source: reuters.com
7 Vaccines in Clinical Trials in Republic of Korea
-
Inovio
INO-4800- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
6 trials in 3 countries
-
EuBiologics Co Ltd
EuCorVac-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
SK Bioscience Co Ltd
GBP510- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
4 trials in 1 country
-
GeneOne Life Science Inc
GLS-5310- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Genexine
GX-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
4 trials in 1 country
-
Cellid Co
AdCLD-CoV19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
SK Bioscience Co Ltd
NBP2001- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country